Advanced searches left 3/3
Search only database of 12 mil and more summaries
Colorectal Cancer
Summarized by PlexPage
Last Updated: 22 January 2022
* If you want to update the article please login/register
General | Latest Info
Colorectal Cancer
| Other names | Colon cancer, rectal cancer, bowel cancer |
| Specialty | Gastroenterology General surgery Oncology |
| Symptoms | vomiting blood , Blood in the stool , change in bowel movements, weight loss , fatigue. |
| Causes | Old age, lifestyle factors, genetic disorders |
| Risk factors | Diet, obesity , smoking, lack of physical activity , alcohol use |
| Diagnostic method | Tissue biopsy during a sigmoidoscopy or colonoscopy |
| Prevention | Screening from age of 50 to 75 |
| Treatment | Surgery, radiation therapy , chemotherapy , targeted therapy |
| Prognosis | Five-year survival rate 65% (US) |
| Frequency | 9.4 million (2015) |
| Deaths | 551,000 (2018) |
"colorectal cancer | Ad for colorectal cancer awareness in th… | Flickr", by Flickr, licensed under CC BY 2.0
Colon cancer is a kind of cancer that starts in the big intestine. When physicians discuss colorectal cancer, they're generally chatting about this type. Some sub-types of adenocarcinoma, such as signet ring and mucinous, might have an even worse prognosis than various other subtypes of adenocarcinoma.
Gastrointestinal stromal tumors begin from unique cells in the wall of the colon called the interstitial cells of Cajal. Sarcomas can begin in capillary, muscle layers, or other connective tissues in the wall of the colon and rectum. Colorectal cancer starts in the rectum or the colon.
Colon cancer and anal cancer are frequently organized with each other because they have many attributes alike. The colon and anus comprise the big intestine, which belongs to the digestive system, additionally called the intestinal system. The descending and sigmoid colon are called the distal colon. The colon takes in water and salt from the staying food matter after it undergoes the little intestine.
As a whole, colon cancer begins when healthy cells in the colon create modifications in their DNA. Colon cancer can be detected at any type of age, but a majority of people with colon cancer are older than 50. If you've already had colon cancer or noncancerous colon polyps, you have a higher danger of colon cancer in the future.
The most typical acquired disorders that increase colon cancer threat are familial adenomatous polyposis and Lynch syndrome, which is additionally recognized as hereditary nonpolyposis colorectal cancer. Some studies have discovered an enhanced danger of colon cancer in people who consume diet regimens high in red meat and refined meat. People who are overweight have an increased danger of colon cancer and an increased danger of passing away of colon cancer when compared to people taken into consideration normal weight.
Colorectal cancer occurs when tumors form in the lining of the huge intestinal tract. The risk of creating colorectal cancer climbs after age 50. Treatments for colorectal cancer consist of surgical treatment, radiation treatment, radiation, or a combination.
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.
Recommendations
Related video
16 October 2017 • Colorectal Cancer - Overview
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions
Colorectal Cancer (latest news)
Data Presented Include Case-collected and possible Samples and Show Improved Specificity of 92%, High Sensitivity for Colorectal Cancer at 95%, and Precancerous Lesion Sensitivity of 57% Data Presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium Exact Sciences and Mayo Clinic will Host a Conference Call and Webcast at 11 am ET on Wednesday, January 19 to Discuss Results of the Study MADISON, Wis. , Jan. 18 2022/ PRNewswire/-Exact Sciences Corp. Today introduced efficiency data for a second-generation Cologuard Colorectal cancer is the 2nd most dangerous cancer impacting both men and women in the United States. When they need to be checked once again, patients with a negative test result ought to talk about with their medical professional.
In a medical study, 13% of people without cancer got a positive result and 8% of people with cancer got a negative outcome.
Adele Roberts has talked out about her'shock' cancer diagnosis and outlined the impacts of her surgical procedure to eliminate the tumour.
Adele first located popularity when she took component in the third series of Big Brother in 2002 along with fellow housemates Jade Goody, Alison Hammond and winner Kate Lawler. Participating in a panel organized by charity RU Coming Out as reported by Gay Star News, she clarified: 'I had gone to college and had a sweetheart and everybody was cool about it, but I hadn't had that talk with my mum and father.
According to Bowel Cancer UK numbers, more than 41200 people are identified with bowel cancer every year in the UK. 12 of 35 patients dealt with per method at the recommended Phase 2 dosage in combination with FOLFIRI and bevacizumab attained a complete response or partial response-17 of 48 patients throughout all dose degrees accomplished a CR or PR.
As we have increased the variety of patients reviewed and the period of follow-up, our Phase 1b/ 2 test has regularly produced data recommending that onvansertib offers significant scientific advantages when included in SOC, stated Katherine L. Ruffner, MD, primary clinical officer of Cardiff Oncology.
About the Phase 1b/ 2 Trial of Onvansertib in the Second-Line Treatment of KRAS-mutated mCRC This is a multi-center, single-arm, Phase 1b/ 2 trial of onvansertib in combination with standard-of-care FOLFIRI and Avastin to examine the safety and security and preliminary efficiency of the combination regimen in the second-line treatment of patients with KRAS-mutated mCRC. The trial, A Phase 1b/ 2 Study of Onvansertib in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation, is enlisting patients with histologically validated metastatic and unresectable colorectal cancer nurturing a KRAS anomaly.
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions
Sources
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.
* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions
Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.
Partners:
Contact
General contact: contant@plex.page
© All rights reserved
2022 made by Algoritmi Vision Inc.
If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.
If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.